IRIS
BRUZZONE, BIANCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.148
AS - Asia 1.086
NA - Nord America 626
SA - Sud America 93
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 8.979
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.950
US - Stati Uniti d'America 577
SG - Singapore 414
CN - Cina 292
VN - Vietnam 221
FR - Francia 59
BR - Brasile 58
HK - Hong Kong 37
DE - Germania 31
BD - Bangladesh 24
FI - Finlandia 21
GB - Regno Unito 21
AR - Argentina 20
CA - Canada 18
MX - Messico 16
IQ - Iraq 14
IN - India 13
JP - Giappone 13
PH - Filippine 9
RU - Federazione Russa 7
ES - Italia 6
PK - Pakistan 6
PL - Polonia 6
TH - Thailandia 6
UA - Ucraina 6
EC - Ecuador 5
ID - Indonesia 5
JO - Giordania 5
NL - Olanda 5
TR - Turchia 5
ZA - Sudafrica 5
AT - Austria 4
CH - Svizzera 4
ET - Etiopia 4
JM - Giamaica 4
RO - Romania 4
SA - Arabia Saudita 4
VE - Venezuela 4
CL - Cile 3
HR - Croazia 3
IE - Irlanda 3
MA - Marocco 3
TN - Tunisia 3
UZ - Uzbekistan 3
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
EG - Egitto 2
GA - Gabon 2
GR - Grecia 2
HU - Ungheria 2
KE - Kenya 2
KR - Corea 2
LT - Lituania 2
MY - Malesia 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
SV - El Salvador 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
HN - Honduras 1
IR - Iran 1
KY - Cayman, isole 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
MK - Macedonia 1
MT - Malta 1
PA - Panama 1
PS - Palestinian Territory 1
SE - Svezia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 8.979
Salva come PNG Salva come JPEG
Città #
Genoa 3.026
Genova 2.457
Vado Ligure 698
Rapallo 651
Singapore 198
San Jose 160
Ho Chi Minh City 71
Ashburn 63
Beijing 61
Hanoi 56
Lauterbourg 54
Council Bluffs 52
Hong Kong 36
New York 32
Bordighera 30
Helsinki 21
Frankfurt am Main 19
Los Angeles 13
Milan 12
Santa Clara 12
Tokyo 12
Haiphong 10
Buffalo 9
Da Nang 9
Mexico City 9
Rome 9
Atlanta 8
Orem 7
São Paulo 7
City of London 6
London 6
Tianjin 6
Amman 5
Hải Dương 5
Kyiv 5
Toronto 5
Baghdad 4
Biên Hòa 4
Can Tho 4
Dallas 4
Denver 4
Guangzhou 4
Hangzhou 4
Houston 4
Montreal 4
Paris 4
Warsaw 4
Zurich 4
Amsterdam 3
Chennai 3
Chicago 3
Columbus 3
Dublin 3
Itaquaquecetuba 3
Karbala 3
Ninh Bình 3
Nuremberg 3
Salt Lake City 3
Shenzhen 3
Tashkent 3
Vinh 3
Zagreb 3
Acalanes Ridge 2
Addis Ababa 2
Bangkok 2
Bari 2
Bauru 2
Birmingham 2
Brasília 2
Buenos Aires 2
Cairo 2
Cape Town 2
Cardiff 2
Cologne 2
Curitiba 2
Eagleville 2
Fortaleza 2
Go Vap 2
Jakarta 2
Johannesburg 2
Kingston 2
Libreville 2
Lomas de Zamora 2
Madrid 2
Maracaibo 2
Modena 2
Moscow 2
Nha Trang 2
Ospitaletto 2
Phoenix 2
Piscataway 2
Pristina 2
Quận Ba 2
Riverside 2
Riyadh 2
San Francisco 2
San José 2
San Salvador 2
Thái Nguyên 2
Xi'an 2
Totale 8.006
Salva come PNG Salva come JPEG
Nome #
Fifteen years of epidemiologic, virologic and syndromic influenza surveillance: A focus on type B virus and the effects of vaccine mismatch in Liguria region, Italy 252
Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc 236
Correct Identification of Dual HCV Infections in HIV/HCV CoInfected Patients 212
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 192
Analysis of a 3-months measles outbreak in western Liguria, Italy: Are hospital safe and healthcare workers reliable? 192
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 175
Bloodstream infections in critically ill patients with COVID-19 173
Resolution of porphyria cutanea tarda in HIV and mixed HCV coinfection after direct-acting antiviral (DAA) therapy 170
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab 168
Overview of hepatitis B virus mutations and their implications in the management of infection 168
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 162
Simplification to monotherapy with lopinavir/ritonavir in adolescents with vertically acquired HIV-1 infection. 157
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 155
How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis 155
Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy 148
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 148
Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study 146
Pregnancy outcomes following exposure to efavirenz-based antiretroviral therapy in the Republic of Congo 143
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 143
Ligurian Vaccination in HIV Program (LIV in HIV): the experience of Genoa metropolitan area 142
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group 141
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 141
CD8+CD28-CD127loCD39+Treg Expansion: a New Pathogenic Mechanism for HIV Infection? 140
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 139
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 131
Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers 131
Effect of the 2020/21 season influenza vaccine on SARS-CoV-2 infection in a cohort of Italian healthcare workers 130
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 129
From a medical mistake to a clinical warning: The case of HBV mutant virus reactivation in haematological patients 129
Vaginal HIV-1 shedding among HIV-1 infected women in the current era of combined antiretroviral therapy: a cross sectional study 128
Adverse Reactions after the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine among Medical School Residents in a Regional Reference University Hospital in Italy 126
Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients 126
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 126
Distinct features of immune activation and exhaustion markers in people with perinatally-acquired HIV 124
Unexpected high rate of wild-type HIV-1 genotype among inmates failing antiretroviral therapy 124
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 123
Xpert HIV-1 viral load assay and versant HIV-1 RNA 1.5 assay: A performance comparison 123
Acceptance of COVID-19 and Influenza Vaccine Co-Administration: Insights from a Representative Italian Survey 121
Short Communication: Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis? 118
Characterization of T lymphocytes in severe COVID-19 patients 118
Comparative diagnostic performance of rapid antigen detection tests for COVID-19 in a hospital setting 117
Comparative Analysis of Five Multiplex RT-PCR Assays in the Screening of SARS-CoV-2 Variants 116
Determinants of SARS-CoV-2 infection in Italian healthcare workers: a multicenter study 112
Comparative Diagnostic Accuracy of the {STANDARD} M10 Assay for the Molecular Diagnosis of {SARS}-{CoV}-2 in the Point-of-Care and Critical Care Settings 111
Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA) 111
Comparative diagnostic performance of a novel reverse transcription loop-mediated isothermal amplification (RT-LAMP) kit for the rapid detection of SARS-CoV-2 109
Effect of SARS-CoV-2 vaccination in a vulnerable COVID-19 cohort: a real-life experience in an Italian Hospital 106
Changes in attitudes and beliefs concerning vaccination and influenza vaccines between the first and second covid-19 pandemic waves: A longitudinal study 102
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen 101
Immunological profile of an infant treated with integrase inhibitor from the neonatal period 99
Emerging mutations at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine 96
Investigating SARS-CoV-2 transmission among co-workers in a University of Northern Italy during COVID-19 pandemic: an observational study 96
Prevalence of mutations and determinants of genotypic resistance to etravirine (TMC125) in a large Italian resistance database (ARCA) 92
Reactogenicity of bnt162b2 mrna covid-19 vaccine in a young working age population: A survey among medical school residents, within a mass vaccination campaign, in a regional reference teaching hospital in italy 92
Monkeypox outbreak in Genoa, Italy: Clinical, laboratory, histopathologic features, management, and outcome of the infected patients 90
Duration of isolation and precautions in immunocompromised patients with COVID-19 90
Nasal monkeypox virus infection successfully treated with cidofovir in a patient newly diagnosed with HIV 89
Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients 88
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection 88
Mortality of Pneumocystis jirovecii pneumonia in intensive care units: a post-hoc analysis of an international multicenter study by ESGCIP and EFISG 87
Impact of the M184V resistance mutation on virological efficacy and durability of lamivudine-based dual antiretroviral regimens as maintenance therapy in individuals with suppressed HIV-1 RNA: A cohort study 87
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge 85
Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohort 85
Outbreak of sars-cov-2 lineage 20i/501y.V1 in a nursing home underlines the crucial role of vaccination in both residents and staff 83
Co-detection of respiratory pathogens among ILI patients: characterization of samples collected during the 2018/19 and 2019/20 pre-pandemic seasons 83
No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020 80
Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B 78
Update on emergence of HIV-1 resistance to antiretroviral drug classes in an Italian national database: 2007-2009 78
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings 77
Efficacy of the Sentinox Spray in Reducing Viral Load in Mild COVID-19 and Its Virucidal Activity against Other Respiratory Viruses: Results of a Randomized Controlled Trial and an In Vitro Study 70
Darunavir-based dual therapy in HIV experienced patients 68
How Long Can a Dead Body Remain Infectious?: Postmortem Nasopharyngeal Swabs and SARS-CoV-2 Culture in a Corpse Over an 87-Day Period 66
Evaluation of extraction-free RT-qPCR methods for SARS-CoV-2 diagnostics 60
Real-world performance of SARS-CoV-2 rapid antigen testing through the Alpha-, Delta- and Omicron-dominant waves of the COVID-19 pandemic 48
Marked decrease in acquired resistance to antiretrovirals in latest years in Italy 45
96-week real-world effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in HIV-infected adults with pre-existing NRTI resistance: a retrospective cohort study 42
Herpes Simplex Virus 1 (HSV-1) Reactivation in Critically Ill COVID-19 Patients: A Brief Narrative Review 19
PREVALENCE OF ETRAVIRINE (ETR)-RESISTANCE ASSOCIATED MUTATIONS AT NNRTI FAILURE AND PREDICTORS OF RESISTANCE TO ETR IN A LARGE ITALIAN RESISTANCE DATABASE (ARCA) 13
Prevalence of etravirine (ETR)-RAMs at NNRTI failure and predictors of resistance to ETR in a large Italian resistance database (ARCA) 6
A Cluster Randomized Study to Explore Case Definitions, Clinical Course and Consequences of RSV in Community-Dwelling Adults Aged ≥ 50 Years 3
Diagnostic Accuracy of Five Molecular Assays for the Detection of Dengue Virus 1
Totale 9.174
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.929
article - articoli 33.501
book - libri 0
conference - conferenze 428
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.858
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 0 0 0 0 0 0 30 37
2021/2022597 40 16 23 76 19 33 37 119 64 58 24 88
2022/2023817 73 83 2 68 91 122 8 42 128 50 137 13
2023/2024669 29 72 12 86 66 121 40 48 28 27 46 94
2024/20251.954 58 106 49 143 203 210 253 377 64 94 197 200
2025/20263.158 429 85 313 273 405 197 446 201 316 317 176 0
Totale 9.174